Drug reference directory
Drug reference

fluticasone propionate

Corticosteroid · Anti-inflammatory

CorticosteroidAnti-inflammatory
CDSCO approved
EXCRETION
—
not curated
INTERACTIONS
—
none in our sources
PREGNANCY
—
not curated

Mechanism

Corticosteroids enter target cells and bind to glucocorticoid receptors (GRs) in the cytoplasm. The steroid-GR complex moves into the nucleus, binding to specific DNA sequences to increase or decrease gene transcription, or interacting with protein transcription factors (e.g., AP-1, NF-κB) and coactivators. This suppresses inflammation by inhibiting inflammatory genes, preventing inflammatory cell recruitment, inhibiting cytokine formation, decreasing eosinophil survival, preventing vascular permeability, and inhibiting mucus secretion.

Indications

Asthma (in combination with LABA)AsthmaVariety of dermatological conditions

Dosing

Adult
100–250 µg BD (max 1000 µg/day) by inhalation

Pharmacokinetics

Bioavailability
Negligible oral bioavailability. The dose swallowed after inhalation has little propensity to produce systemic effects. At high doses, systemic effects may be due to absorption from the lungs.

Side effects

Common
Thinning of epidermisDermal atrophyTelangiectasiaStriaeEasy bruisingHypopigmentationDelayed wound healingFungal and bacterial infections
Serious
  • Adrenal pituitary suppression (with large, repeated amounts)
  • Cushing’s syndrome (rarely)

Drug interactions

10 additional unreviewed or low-confidence interactions hidden because their provenance or source detail is insufficient.

Related guidelines

Other Corticosteroid drugs

Ask House about fluticasone propionate

Continue into a citation-backed clinical answer with the drug context already attached.

Textbook-sourced·Sources: KD Tripathi 7e, Goodman & Gilman 14e·Updated: 2026-05-10